-+ 0.00%
-+ 0.00%
-+ 0.00%

ENLIVEN THERAPEUTICS INC - CONTINUES TO PREPARE FOR PHASE 3 TRIAL INITIATION IN 2026 AND THE COMMERCIALIZATION OF ELVN-001

Reuters·01/07/2026 14:06:08

Please log in to view news